Opdivo (Nivolumab) is approved for the treatment of urothelial carcinoma!

The FDA has expanded the use of Opdivo by US pharmaceutical company Bristol-Myers Squibb, Reuters reported. The drug has been approved for the treatment of urothelial carcinoma.

Opdivo has already been approved for the treatment of melanoma, non-small cell lung cancer, kidney cancer, and Hodgkin's lymphoma.

B Last month, Bristol-Myers Squibb announced that it would not seek FDA approval for the fast review of the Opdivo (nivolumab) and Yervoy (ipilimumab) combination as first-line therapy for lung cancer.

These are useful publications about treatment in Israel

A revolutionary treatment for brain cancer in Israel

Researchers at Tel Aviv University made a startling discovery when they discovered a protein that disrupts the brain's immune system.

More details

Israeli optical technology for diagnosing melanoma

Timely diagnosis of skin cancer, including one of the most severe of its types - melanoma, can be of crucial importance for the patient and save his life.

More details

How much histology is done

We tell you how much analysis for histology is done and how long to wait for the result?

More details

Scientists have figured out how cancer cells "recruit" healthy ones into tumors

Scientists from two Iowa universities used 3D technology for the first time to recreate the process of oncological tumor appearance in real time ...

More details